Pablo Penaloza-MacMaster

Assistant Professor, Microbiology-Immunology
Driskill Graduate Training Program in Life Sciences

Phone312/503-5240
Emailppm@northwestern.edu

Source: Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

The goal of Dr. Penaloza's research is to understand the basic mechanisms of immune regulation and to use this information to develop vaccines and regimens against chronic infections, such as HIV and HCV, as well as cancers.

Training Experience

2014	Postdoctoral Fellowship, Beth Israel Deaconess Medical Center

Education/Academic qualification

PhD, Emory University

… → 2011

Research interests

AIDS
HIV Infection
Immune Regulation
Infectious Diseases
Microbiology
Vaccine Science
Virology

Fingerprint

Dive into the research topics where Pablo Penaloza-MacMaster is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

10 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
4 Finished

Interferon-modulated vaccines against HIV
Penaloza-MacMaster, P.
National Institute on Drug Abuse
7/1/20 → 6/30/24
Project: Research project
T regulatory cell responses during viral infection
Penaloza-MacMaster, P.
National Institute of Allergy and Infectious Diseases
6/8/18 → 5/31/20
Project: Research project
Development of Immune-Modulated HIV Vaccines
Penaloza-MacMaster, P.
National Institute of Allergy and Infectious Diseases
8/15/16 → 7/31/18
Project: Research project
Subproject for Institution # SP0033269 Institutional Research Grant for Dr. Pablo Penaloza-MacMaster
Penaloza-MacMaster, P.
American Cancer Society
1/1/16 → 12/31/18
Project: Research project
Improving HIV-specific antibody responses
Penaloza-MacMaster, P.
National Institute of Allergy and Infectious Diseases
4/9/15 → 3/31/20
Project: Research project

1121 Citations
32 Article
1 Short survey
1 Review article

Early type I IFN blockade improves the efficacy of viral vaccines
Palacio, N., Dangi, T., Chung, Y. R., Wang, Y., Loredo-Varela, J. L., Zhang, Z. & Penaloza-MacMaster, P., Dec 7 2020, In: Journal of Experimental Medicine. 217, 12, 20191220.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Interrogating Adaptive Immunity Using LCMV
Dangi, T., Chung, Y. R., Palacio, N. & Penaloza-MacMaster, P., Sep 1 2020, In: Current Protocols in Immunology. 130, 1, e99.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection
Wang, Y., Chung, Y. R., Eitzinger, S., Palacio, N., Gregory, S., Bhattacharyya, M. & Penaloza-MacMaster, P., Feb 2019, In: PLoS pathogens. 15, 2, e1007583.
Research output: Contribution to journal › Article › peer-review

Open Access
7 Scopus citations
Adenovirus vector vaccination impacts NK cell Rrheostat function following lymphocytic choriomeningitis virus infection
Blass, E., Aid, M., Martinot, A. J., Larocca, R. A., Kang, Z. H., Badamchi-Zadeh, A., Penaloza-MacMaster, P., Reeves, R. K. & Barouch, D. H., Jun 1 2018, In: Journal of virology. 92, 11, e02103-17.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Combined HDAC and BET inhibition enhances melanoma vaccine immunogenicity and efficacy
Badamchi-Zadeh, A., Moynihan, K. D., Larocca, R. A., Aid, M., Provine, N. M., Justin Iampietro, M., Kinnear, E., Penaloza-MacMaster, P., Abbink, P., Blass, E., Tregoning, J. S., Irvine, D. J. & Barouch, D. H., Nov 1 2018, In: Journal of Immunology. 201, 9, p. 2744-2752 9 p.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations